Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's risk communication plan coming soon

This article was originally published in The Tan Sheet

Executive Summary

FDA could release its strategic plan to ensure it accurately communicates to consumers the risks and benefits of medical products in as early as one month, according to Janet Woodcock, director of the Center for Drug Evaluation and Research. The plan will include a list of 14 actions FDA will take in the next year to improve its risk communication strategies. It will also list around 60 actions FDA hopes to take in the next few years, Woodcock said Sept. 21 at the Food and Drug Law Institute conference in Washington
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103388

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel